V019-2795 Screening compound: 2-(4-{3-[3-(3-chloro-4-methylphenyl)-5-oxo-2,5-dihydro-1,2,4-triazin-6-yl]propanoyl}piperazin-1-yl)-N-(propan-2-yl)acetamide

V019-2795 Screening compound: 2-(4-{3-[3-(3-chloro-4-methylphenyl)-5-oxo-2,5-dihydro-1,2,4-triazin-6-yl]propanoyl}piperazin-1-yl)-N-(propan-2-yl)acetamide
V019-2795 Screening compound: 2-(4-{3-[3-(3-chloro-4-methylphenyl)-5-oxo-2,5-dihydro-1,2,4-triazin-6-yl]propanoyl}piperazin-1-yl)-N-(propan-2-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-2795
2-(4-{3-[3-(3-chloro-4-methylphenyl)-5-oxo-2,5-dihydro-1,2,4-triazin-6-yl]propanoyl}piperazin-1-yl)-N-(propan-2-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-2795

Molecular Formula

C22H29ClN6O3 (C22 H29 ClN6 O3)

Compound Name

2-(4-{3-[3-(3-chloro-4-methylphenyl)-5-oxo-2,5-dihydro-1,2,4-triazin-6-yl]propanoyl}piperazin-1-yl)-N-(propan-2-yl)acetamide

IUPAC name

2-(4-{3-[3-(3-chloro-4-methylphenyl)-5-oxo-25-dihydro-124-triazin-6-yl]propanoyl}piperazin-1-yl)-N-(propan-2-yl)acetamide

SMILES

CC(C)NC(CN(CC1)CCN1C(CCC1=NNC(c2cc(Cl)c(C)cc2)=NC1=O)=O)=O

InChI

InChI=1S/C22H29ClN6O3/c1-14(2)24-19(30)13-28-8-10-29(11-9-28)20(31)7-6-18-22(32)25-21(27-26-18)16-5-4-15(3)17(23)12-16/h4-5,12,14H,6-11,13H2,1-3H3,(H,24,30)(H,25,27,32)

InChI Key

VHAWFKLVCJICQV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14264540

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

460.96

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.673

Distribution Coefficient, logD

1.673

Water Solubility, LogSw

-2.90

Polar Surface Area

89.958

Acid Dissociation Constant (pKa)

8.45

Base Dissociation Constant (pKb)

3.62

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

50.00

V019-2795 in Drug Discovery

Included in Screening Libraries

Protein Arginine Methyltransferases Library (27925 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V019-2795 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-2795?
Check Price and Availability of V019-2795, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-2795 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-2795
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-2795
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-2795 available by request